GENCEBOK

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland

Active ingredients

The drug GENCEBOK contains one active pharmaceutical ingredient (API):

1 Caffeine UNII U26EO4675Q - CAFFEINE CITRATE

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. Read about Caffeine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GENCEBOK Solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BC01	Caffeine	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BC Xanthine derivatives
Discover more medicines within N06BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1826175
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1201465001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 086864
Country: FR	Base de données publique des médicaments	Identifier(s): 63865537
Country: IT	Agenzia del Farmaco	Identifier(s): 048989014
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091009
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 207012
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100440256